Nat Rev Dis Primers. 2015 Jun 18;1:15012. doi: 10.1038/nrdp.2015.12.
PMID:27188208
HTLV-1 encephalitis.
King-Robson J, Hampton T, Rosadas C, Taylor GP, Stanton B.
Pract Neurol. 2022 Feb;22(1):60-63. doi: 10.1136/practneurol-2021-003053. Epub 2021 Aug 30.
PMID:34462338
Tropical spastic paraparesis in autochthon patient.
Baldà Masmiquel M, Navarro Aguirre M, Moreira Villanueva A.
Med Clin (Barc). 2020 Jun 26;154(12):522-523. doi: 10.1016/j.medcli.2019.04.034. Epub 2019 Nov 26.
PMID:31784111
HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report.
Matsuura E, Nozuma S, Shigehisa A, Dozono M, Nakamura T, Tanaka M, Kubota R, Hashiguchi A, Takashima H.
BMC Musculoskelet Disord. 2023 May 6;24(1):355. doi: 10.1186/s12891-023-06461-3.
PMID:37149561
Comparison between the spastic paraplegia rating scale, Kurtzke scale, and Osame scale in the tropical spastic paraparesis/myelopathy associated with HTLV.
Adry RA, Lins CC, Kruschewsky Rde A, Castro Filho BG.
Rev Soc Bras Med Trop. 2012 Jun;45(3):309-12. doi: 10.1590/s0037-86822012000300006.
PMID:22760127
Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Enose-Akahata Y, Jacobson S.
Retrovirology. 2019 Nov 29;16(1):35. doi: 10.1186/s12977-019-0499-5.
PMID:31783764
Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy.